+987.9%
MRNA vs INSM
-40.6%
+1,028.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | INSM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +5.3% | +7.8% | +11.9% |
| 7D | +20.6% | +13.4% | +7.2% | +17.1% |
| 30D | +27.1% | +5.9% | +21.2% | +25.2% |
| 3M | +353.4% | +11.4% | +342.0% | +355.0% |
| 6M | +446.3% | -21.4% | +467.7% | +480.9% |
| YTD | +776.2% | -36.8% | +813.0% | +854.1% |
| 1Y | +987.9% | -39.8% | +1,027.7% | +1,027.2% |
| All | +987.9% | -40.6% | +1,028.5% | +1,027.2% |
Cumulative growth
Daily Returns
Daily percentage return beside INSM.
Daily Out/Under-Performance
Portfolio return minus INSM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INSM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded INSM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling